Growth Metrics

Usana Health Sciences (USNA) Net Cash Flow (2016 - 2026)

Usana Health Sciences has reported Net Cash Flow over the past 16 years, most recently at $3.5 million for Q2 2026.

  • Quarterly Net Cash Flow rose 223.11% to $3.5 million in Q2 2026 from the year-ago period, while the trailing twelve-month figure was -$22.0 million through Apr 2026, up 85.04% year-over-year, with the annual reading at -$28.4 million for FY2026, 80.09% up from the prior year.
  • Net Cash Flow was $3.5 million for Q2 2026 at Usana Health Sciences, down from $11.2 million in the prior quarter.
  • Over five years, Net Cash Flow peaked at $37.0 million in Q4 2022 and troughed at -$176.4 million in Q4 2024.
  • The 5-year median for Net Cash Flow is $4.3 million (2024), against an average of -$9.8 million.
  • Year-over-year, Net Cash Flow soared 1542.61% in 2023 and then tumbled 1011.32% in 2024.
  • A 5-year view of Net Cash Flow shows it stood at $37.0 million in 2022, then tumbled by 47.72% to $19.4 million in 2023, then tumbled by 1011.32% to -$176.4 million in 2024, then skyrocketed by 96.52% to -$6.1 million in 2025, then surged by 157.36% to $3.5 million in 2026.
  • Per Business Quant, the three most recent readings for USNA's Net Cash Flow are $3.5 million (Q2 2026), $11.2 million (Q1 2026), and -$6.1 million (Q3 2025).